Posthumously Conceived Children: Fiduciary and Planning Issues New York Bankers Association – 9/30-10/2/2015 2 Speakers Nancy E. Klotz is Vice President and Senior Trust Counsel with Tompkins Trust Company in Rochester, NY, where she works with clients and their advisors to develop and administer trust and estate plans. Anthony T. Selvaggio is an attorney with the firm of Jill M. Cicero & Associates (Rochester, NY) where he concentrates his practice in the areas of wealth transfer planning, the drafting of Wills and trusts, and representing individual and corporate fiduciaries in the administration of estates and trusts. 3 ART & Prior Statutory Law Advances in assisted reproductive technology Use of assisted reproductive technology a growing phenomenon (medical coverage and employee benefits) Prior statutory framework insufficient to handle the new reality of posthumous conception Split between statutory and case law EPTL 4-1.1(c) and EPTL 5-3.2 Matter of Martin B., 841 N.Y.S.2d 207 (N.Y. Sur. Ct. 2007) 4 Matter of Martin B. Trustee of seven trusts petitioned court for advice and direction. Issue: Are the two children conceived and born after death of their father (deceased son of Grantor) issue and descendants of the grantor for trust purposes? Ruling: Yes, they are issue for this purpose. Reasoning: Court relied on grantor’s intent due to the lack of a sufficient statutory framework. Result: Court implored the NYS legislature to act. 5 EPTL SECTION 4-1.3 Definitions: Consent to Posthumous Use: Genetic Parent, Genetic Material and Genetic Child Require written instrument and authorized representative Written Instrument Requirements: Manner of Execution Revocation Alteration or Revocation by Will Prohibited Provision for Successor Representative Statute provides a sample form – see next slide 6 SAMPLE FORM EPTL 4-1.3(c) 5 I, ____________________________________________________________________, (YOUR NAME AND ADDRESS) CONSENT TO THE USE OF MY (SPERM OR OVA) (REFERRED TO BELOW AS MY "GENETIC MATERIAL") TO CONCEIVE A CHILD OR CHILDREN OF MINE AFTER MY DEATH, AND I AUTHORIZE ________________________________________________________________________ (NAME AND ADDRESS OF PERSON) TO DECIDE WHETHER AND HOW MY GENETIC MATERIAL IS TO BE USED TO CONCEIVE A CHILD OR CHILDREN OF MINE AFTER MY DEATH. IN THE EVENT THAT THE PERSON AUTHORIZED ABOVE DIES BEFORE ME OR IS UNABLE TO EXERCISE THE AUTHORITY GRANTED I DESIGNATE ________________________________________________________________________ (NAME AND ADDRESS OF PERSON) TO DECIDE WHETHER AND HOW MY GENETIC MATERIAL IS TO BE USED TO CONCEIVE A CHILD OR CHILDREN OF MINE AFTER MY DEATH. I UNDERSTAND THAT, UNLESS I REVOKE THIS CONSENT AND AUTHORIZATION IN AWRITTEN DOCUMENT SIGNED BY ME IN THE PRESENCE OF TWO WITNESSES WHO ALSO SIGN THE DOCUMENT, THIS CONSENT AND AUTHORIZATION WILL REMAIN IN EFFECT FOR SEVEN YEARS FROM THIS DAY AND THAT I CANNOT REVOKE OR MODIFY THIS CONSENT AND DESIGNATION BY ANY PROVISION IN MY WILL. SIGNED THIS ____ DAY OF _________________, ______ _____________________________________________ (YOUR SIGNATURE) STATEMENT OF WITNESSES: I DECLARE THAT THE PERSON WHO SIGNED THIS DOCUMENT IS PERSONALLY KNOWN TO ME AND APPEARS TO BE OF SOUND MIND AND ACTING WILLINGLY AND FREE FROM DURESS. HE OR SHE SIGNED THIS DOCUMENT IN MY PRESENCE. I AM NOT THE PERSON AUTHORIZEDIN THIS DOCUMENT TO CONTROL THE USE OF THE GENETIC MATERIAL OF THE PERSON WHO SIGNED THIS DOCUMENT. WITNESS: _____________________________________________ ADDRESS: _____________________________________________ DATE: _______________________ WITNESS: _____________________________________________ ADDRESS: _____________________________________________ DATE: _______________________ 7 Notice, Filing & Time Limits Notice and filing requirements: Burden on authorized representative Required to preserve the inheritance rights of genetic child Notice (EPTL 4-1.3(b)(2)): within seven months to the personal representative of estate if letters testamentary have been issued Filing (EPTL 4-1.3(b)(3)): filed in Surrogate’s Court granting letters within seven months of issuance of letters Time limits: EPTL 4-1.3(b)(4) - the genetic child must be in utero no later than 24 months after the genetic parent’s death or actually born no later than 33 months after the genetic parent’s death. 8 Family Tree Family tree : 9 APPLICATION OF THE STATUTE Fact Pattern for Illustrations: Monica, a genetic parent, dies in February 2015. Monica is divorced from Chandler and has twins, Jack and Erica, age 8. Although Monica had not remarried since her divorce, she had been living with Richard, and they had planned to have a child. Monica’s Will leaves her residuary estate “to her issue, in equal shares, per stirpes.” After Monica’s death, Richard continues with their plan to have a child. In June 2015, the implantation of Monica’s genetic material is successful and results in the birth of her third child, Harriet, in February 2016, just a year after Monica’s death. 10 Assumptions for Illustrations For the purposes of the following illustrations, it is assumed that all the requirements of EPTL 4-1.3 necessary to qualify Harriet as Monica’s genetic child have been met. These include: Monica’s written consent to the use of her genetic material and the appointment of Richard as her authorized representative Richard, as the authorized representative, has fulfilled the necessary notice and filing requirements Harriet has been born within 33 months of Monica’s death, the time limit set by the statute 11 APPLICABILITY TO GENETIC PARENT Testate Estate: EPTL 2-1.3 EPTL 4-1.3(b) Result: Harriet shares equally in Monica’s estate with Jack and Erica Intestate Estate: EPTL 4-1.1(c) EPTL 4-1.3(b) Result: Harriet qualifies as Monica’s distributee and shares equally in Monica’s estate with Jack and Erica 12 APPLICABILITY TO OTHERS Others?: Non-genetic parents. Most likely parents or grandparents of genetic parent. Testate Estate: Additional facts: Assume that Monica’s mother, Judy, died in July 2015, just five months after the death of Monica. Following Monica’s death, Judy had updated her estate planning, signing her Will in April 2015. However, this was before she was told about Richard’s plan to use Monica’s stored genetic material. Judy’s Will leaves her entire estate in equal shares to her children and to the issue of any predeceased child. The Will clearly denotes that distributions to issue will pass per stirpes. Judy had two children, Ross and Monica. EPTL 2-1.3 EPTL 4-1.3(f) Result: Harriet will inherit from Judy’s estate as her issue along with Monica’s twins, Jack and Erica. 13 APPLICABILITY TO OTHERS Intestate Estate: Additional facts: Monica dies in February 2015. Monica’s daughter Harriet is posthumously conceived in June 2015 and born in February 2016. However, this time Judy, Monica’s mother, dies intestate in March 2015. Judy is survived by her son, Ross, and Monica’s twins, Jack and Erica, but Harriet is conceived and born after Judy’s death. EPTL 4-1.3(b) overrides the restrictions of EPTL 4-1.1 only in cases in which the genetic parent dies testate. Result: Harriet will not inherit from her grandmother’s intestate estate and only Monica’s twins, Jack and Erica, will be included along with Ross as distributees. 14 EPTL 4-1.3 & Trusts Testamentary Trusts Additional facts: Monica’s father, Jack, died in 2012, several years before his wife, Judy. Jack’s Will created a trust for Judy’s benefit that terminated on her death in July 2015 in favor of his then living issue, per stirpes. His then living issue included his son, Ross, Monica’s twins, Jack and Erica, and potentially, Harriet. Will Harriet inherit? No, Harriet would be excluded from the definition of issue and would not be a remainder beneficiary of Jack’s trust. Why? EPTL 4-1.3(f) limits applicability to “the wills of persons dying on or after September first, two thousand fourteen.” (date of death, not date of execution) Result: Most existing testamentary trusts (those created prior to effective date) will not benefit posthumously conceived children. What About Lifetime Trusts? EPTL 4-1.3(f) also applies to all lifetime instruments executed prior to September 1, 2014, but which were still subject to the grantor’s power to revoke and amend on such date and to all lifetime instruments executed on or after such date. Accordingly, if Monica’s mother, Judy, had used a revocable living trust which dated back to 1984, this would not change the result that Harriet would be treated as Judy’s issue because the trust was subject to her power to revoke and amend on and after September 1, 2014. 15 EPTL 4-1.3 & Trusts Generation Skipping Trusts: Additional facts: Assume in this case that Harriet’s grandmother, Judy, dies in January 2015 and creates a trust for her children, Ross and Monica, under her Will. The trust benefits both of Judy’s children and terminates on the death of the last of them to die. On termination, the trust distributes the remainder to Judy’s “then living issue, per stirpes.” Assume Harriet’s mother, Monica, dies in 2018 and Harriet is subsequently born in 2019 from the preserved genetic material. As in all the previous examples, the requirements of EPTL 4-1.3 have been satisfied in order to qualify Harriet as Monica’s genetic child. In 2048, Ross dies and the trust terminates. Will Harriet inherit? Yes, because Harriet is alive when the class closes (2048), she is a beneficiary of the remainder of this trust. Concerns: Would Judy desire this result? How would the Trustee know about Harriet? 16 Conclusion: A BRAVE NEW WORLD Potential pitfalls for attorneys, clients and fiduciaries Unanswered question – what application will the statute have on beneficiary designations and TOD designations? Bottom line: This seemingly esoteric issue will impact professionals in the trust, estate and financial services industry. Given anticipated advances in technology, this issue will only grow in importance. It is a brave new world!